ArticleJournal of the American Academy of Dermatology2020

The risk of respiratory tract infections and symptoms in psoriasis patients treated with interleukin 17 pathway-inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic.

Marilyn T Wan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.